Clinical Factors
Inclusion Criteria: All patients Timing: Baseline and annually until positive diagnosis of diabetes Reporting Source: Clinician-reported Type: Single answer
integer
Supporting Definition: Fasting plasma glucose value in mg/dL or mmol/L Inclusion Criteria: Optional Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Numerical Response Options: N/A
float
Inclusion Criteria: If fasting plasma glucose value is provided Timing: Baseline and annually Reporting Source: Clinician-reported Type: Single answer
integer
Supporting Definition: Height and weight are used to calculate BMI Inclusion Criteria: All patients Timing: Baseline and annually Reporting Source: Clinician-reported Type: Numerical Response Options: Numerical value
float
Inclusion Criteria: All patients Timing: Baseline and annually Reporting Source: Clinician-reported Type: Single answer
integer
Inclusion Criteria: All patients Timing: Baseline and annually Reporting Source: Clinician-reported Type: Single answer
integer
Inclusion Criteria: If answered 1 to LIPIDLOW Timing: Baseline and annually Reporting Source: Clinician-reported Type: Single answer
integer
Inclusion Criteria: Optional Timing: Baseline and annually Reporting Source: Clinician-reported Type: Single answer
integer
Supporting Definition: Please provide the most recent value Inclusion Criteria: If responded "yes" to CREADONE Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Numerical, enter "000" if unknown Response Options: Numerical value
float
Inclusion Criteria: If value for creatinine is provided Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Single answer
integer
Inclusion Criteria: If value for creatinine is provided Timing: Baseline and annually Reporting Source: Clinician-reported/administratively‐reported Type: Single answer
integer
Treatment variables
Supporting Definition: Non‐pharmacological management includes lifestyle interventions, exercise, diet and other non-pharmacological approaches. Inclusion Criteria: All patients Timing: Baseline and annually Reporting Source: Clinician-reported Type: Single answer
integer
Supporting Definition: Please select all options that apply Inclusion Criteria: If answered '1' to treatment approach (TX) Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Multiple answer
boolean
Supporting Definition: Please select all options that apply Inclusion Criteria: If answered '1' to treatment approach (TX) Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Multiple answer
boolean
Supporting Definition: Please select all options that apply Inclusion Criteria: If answered '1' to treatment approach (TX) Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Multiple answer
boolean
Supporting Definition: Please select all options that apply Inclusion Criteria: If answered '1' to treatment approach (TX) Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Multiple answer
boolean
Supporting Definition: Please select all options that apply Inclusion Criteria: If answered '1' to treatment approach (TX) Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Multiple answer
boolean
Supporting Definition: Please select all options that apply Inclusion Criteria: If answered '1' to treatment approach (TX) Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Multiple answer
boolean
Supporting Definition: Please select all options that apply Inclusion Criteria: If answered '1' to treatment approach (TX) Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Multiple answer
boolean
Supporting Definition: Please select all options that apply Inclusion Criteria: If answered '1' to treatment approach (TX) Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Multiple answer
boolean
Survival, disease control and cardiovascular complications
Inclusion Criteria: All patients Timing: Minimum annually Reporting Source: Clinician‐reported Type: Numerical Response Options: Numerical value
integer
Inclusion Criteria: All patients Timing: Minimum annually Reporting Source: Clinician‐reported Type: Numerical Response Options: Numerical value
integer
Inclusion Criteria: All patients Timing: At time of death Reporting Source: Clinician-reported/administratively‐reported Type: Single answer
integer
Inclusion Criteria: If answered 'yes' to overall survival (OVERALLSURV) Timing: At time of death Reporting Source: Clinician-reported/administratively‐reported Type: Date by DD/MM/YYYY or by MM/YYYY (in case exact day is unknown) Response Options: DD/MM/YYYY or MM/YYYY
date
Inclusion Criteria: If answered 'yes' to overall survival (OVERALLSURV) Timing: At time of death Reporting Source: Clinician-reported/administratively‐reported Type: Single answer
integer
Inclusion Criteria: All patients Timing: Annually and 4-‐6 weeks after initiation or change of treatment Reporting Source: Clinician‐reported Type: Single answer
integer
Supporting Definition: Hypotension and clinical manifestations of hypotension Inclusion Criteria: If answered 'yes' to medication side effects ('MEDEFFECTS') Timing: Annually and 4-6 weeks after initiation or change of treatment Reporting Source: Clinician-reported Type: Multiple answer
boolean
Supporting Definition: Hypotension and clinical manifestations of hypotension Inclusion Criteria: If answered 'yes' to medication side effects ('MEDEFFECTS') Timing: Annually and 4-6 weeks after initiation or change of treatment Reporting Source: Clinician-reported Type: Multiple answer
boolean
Supporting Definition: Hypotension and clinical manifestations of hypotension Inclusion Criteria: If answered 'yes' to medication side effects ('MEDEFFECTS') Timing: Annually and 4-6 weeks after initiation or change of treatment Reporting Source: Clinician-reported Type: Multiple answer
boolean
Supporting Definition: Hypotension and clinical manifestations of hypotension Inclusion Criteria: If answered 'yes' to medication side effects ('MEDEFFECTS') Timing: Annually and 4-6 weeks after initiation or change of treatment Reporting Source: Clinician-reported Type: Multiple answer
boolean
Supporting Definition: Hypotension and clinical manifestations of hypotension Inclusion Criteria: If answered 'yes' to medication side effects ('MEDEFFECTS') Timing: Annually and 4-6 weeks after initiation or change of treatment Reporting Source: Clinician-reported Type: Multiple answer
boolean
Supporting Definition: Hypotension and clinical manifestations of hypotension Inclusion Criteria: If answered 'yes' to medication side effects ('MEDEFFECTS') Timing: Annually and 4-6 weeks after initiation or change of treatment Reporting Source: Clinician-reported Type: Multiple answer
boolean
Supporting Definition: Hypotension and clinical manifestations of hypotension Inclusion Criteria: If answered 'yes' to medication side effects ('MEDEFFECTS') Timing: Annually and 4-6 weeks after initiation or change of treatment Reporting Source: Clinician-reported Type: Multiple answer
boolean
Supporting Definition: Hypotension and clinical manifestations of hypotension Inclusion Criteria: If answered 'yes' to medication side effects ('MEDEFFECTS') Timing: Annually and 4-6 weeks after initiation or change of treatment Reporting Source: Clinician-reported Type: Multiple answer
boolean
Supporting Definition: Hypotension and clinical manifestations of hypotension Inclusion Criteria: If answered 'yes' to medication side effects ('MEDEFFECTS') Timing: Annually and 4-6 weeks after initiation or change of treatment Reporting Source: Clinician-reported Type: Multiple answer
boolean
Supporting Definition: Hypotension and clinical manifestations of hypotension Inclusion Criteria: If answered 'yes' to medication side effects ('MEDEFFECTS') Timing: Annually and 4-6 weeks after initiation or change of treatment Reporting Source: Clinician-reported Type: Multiple answer
boolean
Supporting Definition: Myocardial infarction (ICD10: I21) or angina (ICD10: I20) diagnosed by a clinician Inclusion Criteria: All patients Timing: Annually Reporting Source: Clinician-reported Type: Single answer
integer
Supporting Definition: Cerebrovascular accident (ICD10: I60 ‐ Subarachnoid haemorrhage, I61 – Intracerebral haemorrhage, I62 – other non-‐traumatic intracranial haemorrhage, I63 – cerebral infarction, I64 -‐ Stroke, not specified as haemorrhage or infarction) or transient ischaemic attack (ICD10: G45 ‐ Transient cerebral ischaemic attacks and related syndromes) diagnosed by a clinician Inclusion Criteria: All patients Timing: Annually Reporting Source: Clinician‐reported Type: Single answer
integer
Supporting Definition: Atrial fibrillation (ICD10: I48.0 paroxysmal atrial fibrillation, I48.1 – persistent atrial fibrillation, I48.2 Chronic atrial fibrillation) diagnosed by a clinician Inclusion Criteria: All patients Timing: Annually Reporting Source: Clinician-reported Type: Single answer
integer
Supporting Definition: Heart failure (ICD10: I50 ‐ Heart failure, ICD:10 I11.0 – hypertensive heart disease with (congestive) heart failure) diagnosed by a clinician Inclusion Criteria: All patients Timing: Annually Reporting Source: Clinician-reported Type: Single answer
integer
Inclusion Criteria: If answered 'yes' to heart failure ('HF') Timing: Annually Reporting Source: Clinician-reported Type: Single answer
integer
Supporting Definition: Peripheral artery disease (ICD:10 I70.2 -‐ Atherosclerosis of arteries of extremities) diagnosed by clinician Inclusion Criteria: All patients Timing: Annually Reporting Source: Clinician-reported Type: Single answer
integer
Supporting Definition: Renal disease (ICD10: I12 Hypertensive renal disease incl. any condition in N00-‐ N07, N18.-‐, N19 or N26 due to hypertension) (Please ensure that other causes of proteinuria, such as urinary tract infection, have been ruled out) Inclusion Criteria: All patients Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Single answer
integer
Inclusion Criteria: If "yes" to CKD Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Single answer
integer
Inclusion Criteria: If responded "1" or "2" to PROTEINEVID Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Single response
integer
Inclusion Criteria: If responded "3" to PROTEINEVID Timing: Baseline and annually Reporting Source: Clinician-reported Type: Numerical Response Options: Numerical value
float
Inclusion Criteria: If ACR value provided Timing: Baseline and annually Reporting Source: Clinician‐reported Type: Single answer
integer
Supporting Definition: Hypertensive urgency is an acute rise in BP >180/120 mmHg with no evidence of acute end-organ damage. Hypertensive emergency is an acute rise in BP > 180/120 with evidence of acute end organ damage. Inclusion Criteria: All patients Timing: Annually Reporting Source: Clinician‐reported Type: Single answer
integer
Inclusion Criteria: If answered 'yes' to hypertensive urgency/ hypertensive emergency ('HYPTENEMERG') Timing: Annually Reporting Source: Clinician‐reported Type: Single answer
integer
Inclusion Criteria: If answered 'yes' to acute end-‐organ damage ('HYPTENENDORG') Timing: Annually Reporting Source: Clinician-reported Type: Multiple answer
boolean
Inclusion Criteria: If answered 'yes' to acute end-‐organ damage ('HYPTENENDORG') Timing: Annually Reporting Source: Clinician-reported Type: Multiple answer
boolean
Inclusion Criteria: If answered 'yes' to acute end-‐organ damage ('HYPTENENDORG') Timing: Annually Reporting Source: Clinician-reported Type: Multiple answer
boolean
Inclusion Criteria: If answered 'yes' to acute end-‐organ damage ('HYPTENENDORG') Timing: Annually Reporting Source: Clinician-reported Type: Multiple answer
boolean
Inclusion Criteria: If answered 'yes' to acute end-‐organ damage ('HYPTENENDORG') Timing: Annually Reporting Source: Clinician-reported Type: Multiple answer
boolean
Health status